A detailed history of Stephens Investment Management Group LLC transactions in Repligen Corp stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 499,744 shares of RGEN stock, worth $72.2 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
499,744
Previous 512,090 2.41%
Holding current value
$72.2 Million
Previous $64.6 Million 15.21%
% of portfolio
1.05%
Previous 0.93%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.79 - $167.35 $1.48 Million - $2.07 Million
-12,346 Reduced 2.41%
499,744 $74.4 Million
Q2 2024

Aug 06, 2024

BUY
$120.0 - $182.95 $4.84 Million - $7.38 Million
40,358 Added 8.56%
512,090 $64.6 Million
Q1 2024

May 14, 2024

SELL
$170.78 - $208.42 $2.57 Million - $3.14 Million
-15,066 Reduced 3.09%
471,732 $86.8 Million
Q4 2023

Feb 13, 2024

SELL
$114.17 - $185.35 $1.75 Million - $2.84 Million
-15,300 Reduced 3.05%
486,798 $87.5 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $141,833 - $180,393
1,022 Added 0.2%
502,098 $79.8 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $3.79 Million - $4.94 Million
-27,388 Reduced 5.18%
501,076 $70.9 Million
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $2.7 Million - $3.46 Million
-17,490 Reduced 3.2%
528,464 $89 Million
Q4 2022

Jan 26, 2023

BUY
$162.42 - $220.56 $545,081 - $740,199
3,356 Added 0.62%
545,954 $93.3 Million
Q3 2022

Nov 07, 2022

SELL
$160.42 - $256.21 $4.11 Million - $6.56 Million
-25,617 Reduced 4.51%
542,598 $102 Million
Q2 2022

Aug 03, 2022

BUY
$140.68 - $188.02 $1.14 Million - $1.52 Million
8,105 Added 1.45%
568,215 $92.3 Million
Q1 2022

May 04, 2022

BUY
$161.19 - $257.96 $1.8 Million - $2.87 Million
11,144 Added 2.03%
560,110 $105 Million
Q4 2021

Feb 15, 2022

SELL
$247.59 - $304.47 $2.31 Million - $2.84 Million
-9,321 Reduced 1.67%
548,966 $145 Million
Q3 2021

Oct 27, 2021

SELL
$194.77 - $324.21 $11.4 Million - $18.9 Million
-58,346 Reduced 9.46%
558,287 $161 Million
Q2 2021

Aug 09, 2021

SELL
$165.87 - $220.95 $2.41 Million - $3.22 Million
-14,554 Reduced 2.31%
616,633 $123 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $492,590 - $617,916
2,731 Added 0.43%
631,187 $123 Million
Q4 2020

Feb 10, 2021

SELL
$148.08 - $206.57 $6.34 Million - $8.84 Million
-42,789 Reduced 6.37%
628,456 $120 Million
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $5.06 Million - $6.54 Million
-41,301 Reduced 5.8%
671,245 $99 Million
Q2 2020

Aug 24, 2020

SELL
$94.33 - $140.48 $3.41 Million - $5.07 Million
-36,102 Reduced 4.82%
712,546 $88.1 Million
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $2.83 Million - $3.64 Million
33,312 Added 4.66%
748,648 $72.3 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $272,838 - $343,930
-3,695 Reduced 0.51%
715,336 $66.2 Million
Q3 2019

Oct 18, 2019

SELL
$76.65 - $95.51 $1.54 Million - $1.92 Million
-20,085 Reduced 2.72%
719,031 $55.1 Million
Q2 2019

Aug 01, 2019

SELL
$54.2 - $85.95 $6.4 Million - $10.1 Million
-118,062 Reduced 13.77%
739,116 $63.5 Million
Q1 2019

May 03, 2019

SELL
$49.45 - $62.8 $52,021 - $66,065
-1,052 Reduced 0.12%
857,178 $50.6 Million
Q4 2018

Feb 11, 2019

SELL
$48.26 - $68.88 $1.15 Million - $1.64 Million
-23,856 Reduced 2.7%
858,230 $45.3 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $1.54 Million - $1.94 Million
-32,981 Reduced 3.6%
882,086 $48.9 Million
Q2 2018

Aug 10, 2018

SELL
$35.26 - $47.04 $486,905 - $649,575
-13,809 Reduced 1.49%
915,067 $42.8 Million
Q1 2018

May 04, 2018

BUY
$30.92 - $37.27 $510,612 - $615,476
16,514 Added 1.81%
928,876 $33.6 Million
Q4 2017

Feb 05, 2018

SELL
$32.53 - $38.92 $229,987 - $275,164
-7,070 Reduced 0.77%
912,362 $33.1 Million
Q3 2017

Nov 08, 2017

BUY
$36.98 - $46.06 $2.28 Million - $2.84 Million
61,718 Added 7.2%
919,432 $35.2 Million
Q2 2017

Aug 10, 2017

BUY
N/A
857,714
857,714 $35.5 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Stephens Investment Management Group LLC Portfolio

Follow Stephens Investment Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.